Events Archive

Self-care Approach to HIV Prevention

How can self-care transform HIV prevention? Join SSLN on Thursday, October 23, 2025, to explore the future of self-care in HIV prevention programming. This crucial session will equip country champions and stakeholders with the technical knowledge and practical tools needed to lead the way. We will cover the risks and opportunities, outline actionable first steps…

The New Frontier in HIV Pre-exposure Prophylaxis: Lenacapavir Update

In the ongoing search for new methods to address the HIV epidemic, the development of lenacapavir for HIV prevention is a major step forward. Findings from research studies has shown that twice-yearly injection of long-acting lenacapavir provides protection against HIV infection. This discovery offers great promise in advancing our progress towards ending AIDS as a…

Modernising Demand Generation for HIV Prevention

With HIV prevention budgets under increasing pressure, effective and efficient communication is more vital than ever. As prevention options expand from condoms and HIV self-testing to multiple forms of PrEP tailored, impactful demand creation is essential to drive uptake and support informed choice. This session will explore how to generate demand using data-informed strategies, virtual…

From Oral PrEP to LEN: Leveling Up Prevention with the WHO–Jhpiego PrEP Provider Training Toolkit

Recording / Slides This 90-minute webinar, presented by Jhpiego and WHO, is intended for communities, providers, policy makers and advocates interested in pre-exposure prophylaxis (PrEP) for HIV prevention. The presenters will provide an overview of the recently launched WHO and Jhpiego Provider Training Toolkit on Use of Oral and Long-Acting HIV PrEP with case-based scenarios…

HIV Prevention Re-mix: Current tools, new tools, same goal

Join the UNITED! Movement and AVAC to learn more about the future of HIV prevention and what this means for young people. The webinar will cover: Prevention options currently available Long-acting PrEP products, including those currently available, available soon, and in the pipeline An update on the introduction of six month lenacapavir for PrEP Advocacy…

Will Lenacapavir be a lever or a let-down? Lessons, Resources, and Considerations for Implementation in the United States

Lenacapavir for PrEP has tremendous potential to increase access and engagement in the United States, reaching individuals who have been unable to embrace PrEP in its previous formulations. How can we ensure that our implementation lifts up, rather than lets down, individuals and communities who need this innovation most? What can we learn from past…

Supporting PrEP Access: HIV Self-Testing in Uptake and Scale-Up

Slides / Recording This webinar, co-hosted by WHO and PSI, will explore the use of HIV self-testing for PrEP initiation and continuation.

New WHO Guidance on Lenacapavir for Prevention and HIV Testing for Long-Acting PrEP

This 60-minute webinar is intended for communities, providers, policy makers and advocates for PrEP, HIV prevention and HIV testing. We will provide an overview of the key takeaways and new guidance from newly released Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. This is the first webinar in a…

PrEP Implementation: What’s worked and what are we learning

Recording / Slides Pre-exposure prophylaxis (PrEP) has emerged as a critical tool in the global HIV prevention response. Despite its proven efficacy, global uptake of oral PrEP has been slower than anticipated, falling short of UNAIDS’ 2025 targets. However, several countries have successfully scaled up oral PrEP, and in the process learnt significant lessons, many…

Town-Hall – Launch of Key Populations Long-Acting PrEP Demand Forecast

See full slide deck here Join Global Black Gay Men Connect for the official launch of the Key Populations (KP) Long-Acting PrEP Demand Forecast, developed by GBGMC and AVAC in collaboration with Avenir Health. This virtual town hall will spotlight the critical findings of the new forecast, which estimates the future need for long-acting PrEP…